Live fluorescence and transmission-through-dye microscopic study of actinomycin D-induced apoptosis and apoptotic volume decrease

APOPTOSIS ◽  
2013 ◽  
Vol 18 (4) ◽  
pp. 521-532 ◽  
Author(s):  
Neda R. Kasim ◽  
Kateřina Kuželová ◽  
Aleš Holoubek ◽  
Michael A. Model
2004 ◽  
Vol 18 (5) ◽  
pp. 531-538 ◽  
Author(s):  
Alexandra d'Anglemont de Tassigny ◽  
Rachid Souktani ◽  
Patrick Henry ◽  
Bijan Ghaleh ◽  
Alain Berdeaux

APOPTOSIS ◽  
2003 ◽  
Vol 8 (6) ◽  
pp. 631-637 ◽  
Author(s):  
Y. Zhao ◽  
T. L. Brown ◽  
H. Kohler ◽  
S. Müller

2013 ◽  
Vol 32 (6) ◽  
pp. 1551-1565 ◽  
Author(s):  
Stefania Antico ◽  
Maria Giulia Lionetto ◽  
Maria Elena Giordano ◽  
Roberto Caricato ◽  
Trifone Schettino

Antioxidants ◽  
2020 ◽  
Vol 9 (11) ◽  
pp. 1058
Author(s):  
Maria Elena Giordano ◽  
Roberto Caricato ◽  
Maria Giulia Lionetto

Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), a hydrophilic analog of vitamin E, is known for its strong antioxidant activity, being a high radical scavenger of peroxyl and alkoxyl radicals. Under particular conditions, Trolox may also exhibit prooxidant properties. The present work aimed at studying the dual antioxidant/prooxidant behavior of Trolox over a wide range of concentrations (from 2.5 to 160 µM) in HeLa cells. In particular, the study addressed the dose-dependent effects of Trolox on the oxidative cell status and vitality of HeLa cells, focusing on the potential role of the vitamin E analog in the induction of one of the first steps of the apoptotic process, Apoptotic Volume Decrease (AVD). In HeLa cells, Trolox showed significant antioxidant activity, expressed as the ability to reduce the endogenous ROS production detected by the ROS-sensitive probe 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA), at low concentrations (range: 2.5–15 µM), but exerted a dose-dependent prooxidant effect at higher concentrations after 24 h exposure. The prooxidant effect was paralleled by the reduction in cell viability due to the induction of the apoptotic process. The dual behavior, antioxidant at lower concentrations and prooxidant at higher concentrations, was evident also earlier after 2 h incubation, and it was paralleled by the isotonic shrinkage of the cells, ascribed to AVD. The use of SITS, known Cl− channel blocker, was able to completely inhibit the Trolox-induced isotonic cell shrinkage, demonstrating the involvement of the vitamin E analog in the alteration of cell volume homeostasis and, in turn, in the AVD induction. In conclusion, the study shed light on the concentration dependence of the Trolox antioxidant/prooxidant activity in HeLa cells and revealed its role in the induction of one of the first events of apoptosis, AVD, at high concentrations.


2007 ◽  
Vol 282 (50) ◽  
pp. 36692-36703 ◽  
Author(s):  
Sébastien L'Hoste ◽  
Mallorie Poet ◽  
Christophe Duranton ◽  
Radia Belfodil ◽  
Herv é Barriere ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document